BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 28461209)

  • 41. A Risk Analysis Approach to Prioritizing Epidemics: Ebola Virus Disease in West Africa as a Case Study.
    Ajisegiri WS; Chughtai AA; MacIntyre CR
    Risk Anal; 2018 Mar; 38(3):429-441. PubMed ID: 28810081
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The contribution of biological, mathematical, clinical, engineering and social sciences to combatting the West African Ebola epidemic.
    Whitty CJ
    Philos Trans R Soc Lond B Biol Sci; 2017 May; 372(1721):. PubMed ID: 28396466
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Perspectives on West Africa Ebola Virus Disease Outbreak, 2013-2016.
    Spengler JR; Ervin ED; Towner JS; Rollin PE; Nichol ST
    Emerg Infect Dis; 2016 Jun; 22(6):956-63. PubMed ID: 27070842
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Stakeholders' engagement with Ebola therapy research in resource limited settings.
    Folayan MO; Brown B; Haire B; Yakubu A; Peterson K; Tegli J
    BMC Infect Dis; 2015 Jun; 15():242. PubMed ID: 26113124
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ebola virus disease in children during the 2014-2015 epidemic in Guinea: a nationwide cohort study.
    Chérif MS; Koonrungsesomboon N; Kassé D; Cissé SD; Diallo SB; Chérif F; Camara F; Koné A; Avenido EF; Diakité M; Diallo MP; Le Gall E; Cissé M; Karbwang J; Hirayama K
    Eur J Pediatr; 2017 Jun; 176(6):791-796. PubMed ID: 28444452
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Regulatory and Operational Complexities of Conducting a Clinical Treatment Trial During an Ebola Virus Disease Epidemic.
    Rojek AM; Dunning J; Leliogdowicz A; Castle L; Van Lieshout M; Carson G; Sahr F; Olliaro P; Horby PW
    Clin Infect Dis; 2018 Apr; 66(9):1454-1457. PubMed ID: 29206908
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Overview, Control Strategies, and Lessons Learned in the CDC Response to the 2014-2016 Ebola Epidemic.
    Bell BP; Damon IK; Jernigan DB; Kenyon TA; Nichol ST; O'Connor JP; Tappero JW
    MMWR Suppl; 2016 Jul; 65(3):4-11. PubMed ID: 27389903
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ebola from emergence to epidemic: the virus and the disease, global preparedness and perspectives.
    Dhama K; Malik YS; Malik SV; Singh RK
    J Infect Dev Ctries; 2015 May; 9(5):441-55. PubMed ID: 25989163
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Community-based reports of morbidity, mortality, and health-seeking behaviours in four Monrovia communities during the West African Ebola epidemic.
    McLean KE; Abramowitz SA; Ball JD; Monger J; Tehoungue K; McKune SL; Fallah M; Omidian PA
    Glob Public Health; 2018 May; 13(5):528-544. PubMed ID: 27463979
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Foreword.
    Frieden TR
    MMWR Suppl; 2016 Jul; 65(3):1-3. PubMed ID: 27389046
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Update: ebola virus disease epidemic - West Africa, December 2014.
    ; ; ; ; ; ; ;
    MMWR Morb Mortal Wkly Rep; 2014 Dec; 63(50):1199-201. PubMed ID: 25522088
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Update: Ebola virus disease epidemic--West Africa, November 2014.
    ; ; ; ; ; ; ; ; ;
    MMWR Morb Mortal Wkly Rep; 2014 Nov; 63(46):1064-6. PubMed ID: 25412064
    [TBL] [Abstract][Full Text] [Related]  

  • 53. How to treat Ebola virus infections? A lesson from the field.
    Duraffour S; Malvy D; Sissoko D
    Curr Opin Virol; 2017 Jun; 24():9-15. PubMed ID: 28410486
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ebola virus disease in the Democratic Republic of Congo.
    Maganga GD; Kapetshi J; Berthet N; Kebela Ilunga B; Kabange F; Mbala Kingebeni P; Mondonge V; Muyembe JJ; Bertherat E; Briand S; Cabore J; Epelboin A; Formenty P; Kobinger G; González-Angulo L; Labouba I; Manuguerra JC; Okwo-Bele JM; Dye C; Leroy EM
    N Engl J Med; 2014 Nov; 371(22):2083-91. PubMed ID: 25317743
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ebola virus disease epidemic in West Africa: lessons learned and issues arising from West African countries.
    Oleribe OO; Salako BL; Ka MM; Akpalu A; McConnochie M; Foster M; Taylor-Robinson SD
    Clin Med (Lond); 2015 Feb; 15(1):54-7. PubMed ID: 25650199
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ethical considerations in the conduct of research on therapies for the prevention and treatment of Ebola virus disease in developing countries.
    Folayan MO; Haire BG
    Pan Afr Med J; 2015; 22 Suppl 1(Suppl 1):8. PubMed ID: 26740837
    [TBL] [Abstract][Full Text] [Related]  

  • 57. On a path to accelerate access to Ebola vaccines: The WHO's research and development efforts during the 2014-2016 Ebola epidemic in West Africa.
    Henao-Restrepo AM; Preziosi MP; Wood D; Moorthy V; Kieny MP;
    Curr Opin Virol; 2016 Apr; 17():138-144. PubMed ID: 27180074
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Slow response contributed to scale of west African Ebola epidemic, CDC concludes.
    McCarthy M
    BMJ; 2016 Jul; 354():i3814. PubMed ID: 27401324
    [No Abstract]   [Full Text] [Related]  

  • 59. Quality improvement of health systems in an epidemic context: A framework based on lessons from the Ebola virus disease outbreak in West Africa.
    Brugnara L; Pervilhac C; Kohler F; Dramé ML; Sax S; Marx M
    Int J Health Plann Manage; 2020 Jan; 35(1):52-67. PubMed ID: 31120603
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Responses to spread of.Ebola virus disease epidemic in West Africa: A review.
    Ayede A; Osinusi K; Falade AG
    Afr J Med Med Sci; 2016 Jun; 45(2):119-134. PubMed ID: 29465855
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.